Prosperity Consulting Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.5M Buy
11,223
+715
+7% +$731K 0.51% 35
2026
Q1
$9.67M Buy
10,508
+488
+5% +$495K 0.43% 45
2025
Q4
$10.8M Buy
10,020
+139
+1% +$133K 0.48% 36
2025
Q3
$7.54M Buy
9,881
+601
+6% +$447K 0.37% 50
2025
Q2
$7.23M Sell
9,280
-276
-3% -$214K 0.53% 42
2025
Q1
$7.89M Sell
9,556
-97
-1% -$80.7K 0.61% 37
2024
Q4
$7.45M Buy
9,653
+1,308
+16% +$1.08M 0.56% 36
2024
Q3
$7.39M Buy
8,345
+5,066
+154% +$4.55M 0.58% 38
2024
Q2
$2.97M Sell
3,279
-116
-3% -$92.8K 0.4% 65
2024
Q1
$2.64M Buy
3,395
+2,211
+187% +$1.57M 0.33% 84
2023
Q4
$690K Buy
1,184
+570
+93% +$333K 0.23% 83
2023
Q3
$330K Buy
+614
New +$316K 0.15% 108

Other funds holding LLY

Prosperity Consulting Group's LLY Position: Q2 2026 in Review

Prosperity Consulting Group increased its Eli Lilly (LLY) stake by 6.8% in Q2 2026, buying an estimated $731K and bringing the position to 11,223 shares worth $13.5M. The position accounts for 0.51% of the portfolio, ranked #35.

Prosperity Consulting Group first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Prosperity Consulting Group held 11,223 shares of Eli Lilly worth $13.5M as of Q2 2026.
  • Prosperity Consulting Group bought 715 Eli Lilly shares in Q2 2026, an estimated $731K.
  • Eli Lilly made up 0.51% of Prosperity Consulting Group's portfolio in Q2 2026, its #35 holding.
  • Prosperity Consulting Group first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Prosperity Consulting Group's 13F filing for Q2 2026, filed 13 Aug 2026.